Jessica Hagen
Joe Lanzisero, VP of Zeitgeist Design & Production and former Walt Disney imagineer, discusses crafting experiences that captivate and how those methods can be applied within healthcare.
Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.
The company's proprietary technology aims to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.
The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.
The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.
The funds come two years after the company scored a $1.15 billion investment.
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.
Digital health leaders say frameworks already exist that can be adopted for AI regulation, but going too far with rules could stifle innovation.
The U.S. Court of Appeals for the Federal Circuit has temporarily stopped an import ban issued by the International Trade Commission prohibiting the sale of Apple Watch Series 9 and Watch Ultra 2 in the U.S.
The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.